CCRT
Sponsors
National Health Research Institutes, Taiwan, National Cancer Center, Korea, National Taiwan University Hospital, Yonsei University, Sun Yat-sen University
Conditions
Cervical CancerCervical CancersChemoradiotherapyGlioblastomaHepatocellular CarcinomaImmunotherapyLung CancerMalignant Neoplasm of Other Specified Site of Nasopharynx
Phase 1
Phase 2
Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
NCT00620269
Start: 2008-02-29End: 2015-03-31Target: 212Updated: 2011-11-07
Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma
CompletedNCT02425605
Start: 2014-12-03End: 2017-09-22Updated: 2019-02-25
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
NCT03008148
Start: 2018-10-11End: 2025-04-30Target: 288Updated: 2021-05-11
A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial
WithdrawnNCT06866951
Start: 2025-03-01End: 2030-12-31Updated: 2025-12-16
Phase 3
A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma
CompletedNCT00201396
Start: 2003-08-31End: 2011-12-31Updated: 2015-02-25
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
RecruitingNCT05173272
Start: 2023-07-24End: 2028-12-28Target: 286Updated: 2023-12-27
Unknown Phase
Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients
CompletedNCT02604472
Start: 1998-01-31End: 2015-10-31Updated: 2015-11-13
The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
RecruitingNCT04409860
Start: 2020-05-26End: 2029-04-30Target: 120Updated: 2023-04-11
Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr
RecruitingNCT05421650
Start: 2022-08-01End: 2030-12-31Target: 240Updated: 2025-04-09
Toripalimab Combined With Definitive CCRT for LACC Patients
RecruitingNCT06256224
Start: 2024-02-02End: 2028-12-31Target: 150Updated: 2024-04-24